Source:http://linkedlifedata.com/resource/chebi/id/CHEBI:50209
| Predicate | Object |
|---|---|
| rdf:type | |
| skos:definition |
"A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'." []
|
| skos:inScheme | |
| skos:prefLabel |
sophoraflavanone G
|
| skos:altLabel |
(2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one
|
| skos:notation |
Beilstein:8594725 "Beilstein Registry Number",
ChemIDplus:97938-30-2 "CAS Registry Number",
CiteXplore:10839220 "PubMed citation",
CiteXplore:10843587 "PubMed citation",
CiteXplore:17137127 "PubMed citation",
KEGG COMPOUND:C18053 "KEGG COMPOUND",
LIPID MAPS:LMPK12140467 "LIPID MAPS instance",
MetaCyc:CPD-9441 "MetaCyc",
Reaxys:8594725 "Reaxys Registry Number",
Wikipedia:Sophoraflavanone_G "Wikipedia"
|
| skos:broader | |
| skos:relatedSynonym |
C25H28O6,
(2S)-5,7,2',4'-tetrahydroxy-8-lavandulylflavanone,
vexibinol,
[H][C@@](CC=C(C)C)(Cc1c(O)cc(O)c2C(=O)C[C@H](Oc12)c1ccc(O)cc1O)C(C)=C,
InChI=1S/C25H28O6/c1-13(2)5-6-15(14(3)4)9-18-20(28)11-21(29)24-22(30)12-23(31-25(18)24)17-8-7-16(26)10-19(17)27/h5,7-8,10-11,15,23,26-29H,3,6,9,12H2,1-2,4H3/t15-,23+/m1/s1,
InChIKey=XRYVAQQLDYTHCL-CMJOXMDJSA-N
|